Nancy Smith reports a stock award at Tempest Therapeutics

By AlphaYouPublished Oct 2, 2026Form 4

Stocks in this disclosure

Reported activity

Smith Nancy Freda

Reporting filer

Nancy Freda Smith reports a stock award, not an open-market purchase or sale, in Tempest Therapeutics, Inc.. Form 4 filed Oct 2, 2026 lists 1 entry.

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Stock Option (right to buy) (derivative)	Smith Nancy Freda	2026-09-22	A	Grant or award	25000	0.00	25,000	10 days	Filed terms security Title: Stock Option (right to buy) conversion Or Exercise Price: 1.00 transaction Date: 2026-09-22 deemed Execution Date: transaction Form Type: 4 transaction Code: A equity Swap Involved: 0 transaction Timeliness: transaction Shares: 25000 transaction Price Per Share: 0.00 transaction Acquired Disposed Code: A id: F1 expiration Date: 2036-09-22 underlying Security Title: Common Stock underlying Security Shares: 25000 shares Owned Following Transaction: 25000 direct Or Indirect Ownership: D

Owner: Smith Nancy Freda
Date: 2026-09-22
Code: A
Action: Grant or award
Quantity: 25000
Price: 0.00
Following holdings: 25,000
Reporting delay: 10 days
Filed terms and references: Filed terms
security Title: Stock Option (right to buy)
conversion Or Exercise Price: 1.00
transaction Date: 2026-09-22
deemed Execution Date:
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 25000
transaction Price Per Share: 0.00
transaction Acquired Disposed Code: A
id: F1
expiration Date: 2036-09-22
underlying Security Title: Common Stock
underlying Security Shares: 25000
shares Owned Following Transaction: 25000
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Smith Nancy Freda: Director.
F1: The shares subject to each such stock option will vest over a three-year period, with one-third of the award vesting on the first anniversary of the grant date and the remainder of the award vesting in equal monthly installments thereafter, subject to the Reporting Person's continued service.

Prepared automatically from public filing data. Report a correction.